Ensuring that life-saving medicines reach the children who need them requires more than simply procuring products. It depends on strong health systems that can finance, forecast, procure, and deliver essential treatments reliably. In Tanzania, strengthening these systems has been critical to expanding access to the recommended first-line treatment for childhood pneumonia, amoxicillin dispersible tablets (Amox DT).
Over the past decade, Results for Development (R4D) has partnered with the Government of Tanzania and other stakeholders to help expand access to this life-saving treatment. Through a coordinated market shaping effort that addressed financing, supply planning, policy alignment, and supplier engagement, Tanzania has strengthened the systems needed to ensure Amox DT is consistently available in health facilities. These efforts also supported a transition from donor-financed procurement to sustainable domestic financing.
This impact brief highlights how government leadership and targeted market shaping interventions helped expand access to pediatric pneumonia treatment and reduce child mortality while strengthening the systems that sustain it. It also shares lessons for countries and partners working to improve access to essential medicines.
For recommendations on how to continue building on this progress, see the accompanying policy brief.
Additional resources:
Implementation and lessons
- Supporting Tanzania’s Ministry of Health to improve commodity availability through bottom-up quantification
- Sustainable health commodity financing: Lessons from Tanzania’s transition from donor funding
Research and analysis
